Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Cascio Rizzo

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Stroke Research and Treatment|July 1, 2025
Thrombus Composition in Cerebral Venous ThrombosisGhil Schwarz, Angelo Cascio Rizzo, Martina Di Como, et al.
Journal of Neurology|June 17, 2026
Bridging therapy versus mechanical thrombectomy alone in patients with basilar artery occlusion and mild symptoms: a retrospective observational studySimone Bellavia, Andrea M Alexandre, Luca Scarcia, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|February 16, 2026
OUTCOMES PREDICTORS IN PATIENTS WITH BASILAR ARTERY OCCLUSION AND MILD DEFICITS, TREATED WITH MECHANICAL THROMBECTOMY: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDYSimone Bellavia, Andrea M Alexandre, Luca Scarcia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2025
Patterns and predictors of statin therapy after ischemic stroke and TIA: insights from the LIPYDS multicenter studyAngelo Cascio Rizzo, Ghil Schwarz, Matteo Paolucci, et al.
European Stroke Journal|March 29, 2026
Effectiveness and safety of endovascular therapy compared to intravenous thrombolysis in acute ischaemic stroke due to medium-vessel occlusions: a real-world multicentre study from the Italian SITS registryMatteo Farè, Elisa Bianchi, Giulia Benina, et al.
JAMA Network Open|April 28, 2026
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough StrokeLucio D'Anna, Francesca Gabriele, Raffaele Ornello, et al.
European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.
Neurology|April 13, 2026
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial FibrillationMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R StudyLucio D'Anna, Matteo Foschi, Francesca Gabriele, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Stroke Research and Treatment|July 1, 2025
Thrombus Composition in Cerebral Venous ThrombosisGhil Schwarz, Angelo Cascio Rizzo, Martina Di Como, et al.
Journal of Neurology|June 17, 2026
Bridging therapy versus mechanical thrombectomy alone in patients with basilar artery occlusion and mild symptoms: a retrospective observational studySimone Bellavia, Andrea M Alexandre, Luca Scarcia, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|February 16, 2026
OUTCOMES PREDICTORS IN PATIENTS WITH BASILAR ARTERY OCCLUSION AND MILD DEFICITS, TREATED WITH MECHANICAL THROMBECTOMY: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDYSimone Bellavia, Andrea M Alexandre, Luca Scarcia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2025
Patterns and predictors of statin therapy after ischemic stroke and TIA: insights from the LIPYDS multicenter studyAngelo Cascio Rizzo, Ghil Schwarz, Matteo Paolucci, et al.
European Stroke Journal|March 29, 2026
Effectiveness and safety of endovascular therapy compared to intravenous thrombolysis in acute ischaemic stroke due to medium-vessel occlusions: a real-world multicentre study from the Italian SITS registryMatteo Farè, Elisa Bianchi, Giulia Benina, et al.
JAMA Network Open|April 28, 2026
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough StrokeLucio D'Anna, Francesca Gabriele, Raffaele Ornello, et al.
European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.
Neurology|April 13, 2026
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial FibrillationMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R StudyLucio D'Anna, Matteo Foschi, Francesca Gabriele, et al.
Pageof 5